Results 171 to 180 of about 37,793 (186)

Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication

Molecular Cell, 2021
Jack P K Bravo, Tyler L Dangerfield, David W Taylor   +2 more
exaly  

A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir

European Journal of Medicinal Chemistry, 2020
Chengyuan Liang, Lei Tian, Yuzhi Liu
exaly  

Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis

Clinical Microbiology and Infection, 2022
Todd C Lee, Srinivas Murthy, Olivier Del Corpo   +2 more
exaly  

Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola

Antimicrobial Agents and Chemotherapy, 2021
Victoria C Yan, Florian L Müller
exaly  

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2020
Awadhesh Kumar Singh, Ritu Singh, Anoop Misra   +2 more
exaly  

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

Proceedings of the National Academy of Sciences of the United States of America, 2020
Emmie De Wit, Friederike Feldmann, Jacqueline Cronin   +2 more
exaly  

Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis

Infection, 2021
Mulugeta Tarekegn Angamo
exaly  

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Cell Reports, 2020
Andrea J Pruijssers, Amelia S George, Alexandra Schafer   +2 more
exaly  

A comparative study of HPLC and UV spectrophotometric methods for remdesivir quantification in pharmaceutical formulations

Journal of Taibah University for Science, 2021
Ibrahim Bulduk, Erten Akbel
exaly  

<p>A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19</p>

Drug Design, Development and Therapy, 2020
Seyed Mohammadreza Hashemian, Tayebeh Farhadi, Ali Akbar Velayati   +2 more
exaly